Rare Melanoma Responds Well to Immunotherapy Despite Thoughts It Wouldn’t, Study Reports – Immuno-Oncology News
Immuno-Oncology News |
Rare Melanoma Responds Well to Immunotherapy Despite Thoughts It Wouldn't, Study Reports
Immuno-Oncology News A rare type of malignant melanoma is treatable with immunotherapies, according to a new study — overturning previous beliefs that the cancer, called desmoplastic melanoma, is not treatable with such medications. The specific treatments used prevent … |
